Hans-Juergen Woerle - 04 Feb 2025 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
Director
Signature
/s/ Thomas J. DesRosier, Attorney-in-fact for Hans-Juergen Woerle
Issuer symbol
MCRB
Transactions as of
04 Feb 2025
Net transactions value
$0
Form type
4
Filing time
06 Feb 2025, 08:05:04 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (right to buy) Award $0 +120,000 $0.000000 120,000 04 Feb 2025 Common Stock 120,000 $0.8056 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in four substantially equal installments on each anniversary of February 4, 2025 or in full immediately prior to the occurrence of a change in control.